Metallocenyl 7‐ACA Conjugates: Antibacterial Activity Studies and Atomic‐Resolution X‐ray Crystal Structure with CTX‐M β‐Lactamase. (16th April 2020)

• Record Type: Journal Article
• Authors: Lewandowski, Eric M.; Szczupak, Łukasz; Kowalczyk, Aleksandra; Mendoza, Gracia; Arruebo, Manuel; Jacobs, Lian M. C.; Stączek, Paweł; Chen, Yu; Kowalski, Konrad
• Is Part Of: Chembiochem. Volume 21:Number 15(2020)
• Page Start: 2187
• Page End: 2195
• Publication Date: 2020-04-16
• Subjects: Antibacterial -- β-lactamases -- β-lactams -- bioorganometallics -- ferrocene -- ruthenocene -- X-ray; Biochemistry -- Periodicals; Molecular biology -- Periodicals; Pharmaceutical chemistry -- Periodicals; 572
• DOI: 10.1002/cbic.202000054
• Languages: English
• ISSNs: 1439-4227

Abstract

Abstract: The conjugation of organometallic groups to current β‐lactam antibiotics is a field of increasing study due to the ability of certain organometallic groups to enhance the antibiotic potency of these drugs. Herein, we report the antibacterial properties of two metallocenyl (ferrocenyl and ruthenocenyl) 7‐aminocephalosporanic acid (7‐ACA) antibiotic conjugates. Continuing a trend we found in our previous studies, the ruthenocenyl conjugate showed greater antibacterial activity than its ferrocenyl counterpart. Compared with the previously published 7‐aminodesacetoxycephalosporanic acid (7‐ADCA) conjugates, the 3‐acetyloxymethyl group significantly improved the compounds' activity. Furthermore, the Rc‐7‐ACA compound was more active against clinical Staphylococcus aureus isolates than the ampicillin reference. Noticeably, neither of the two new compounds showed an undesirable toxic effect in HeLa and L929 cells at the concentrations at which they displayed strong antibacterial effects. The antibacterial activity of the two metallocenyl 7‐ACA derivatives was further confirmed by scanning electron microscopy (SEM). SEM micrographs showed that bacteria treated with metallocenyl 7‐ACA derivatives feature cell wall damage and morphology changes. Using a CTX‐M‐14 β‐lactamase competition assay based on nitrocefin hydrolysis, we showed that the Rc‐7‐ACA bound more favorably to CTX‐M‐14 than its ferrocenyl counterpart, again confirming the superiority of the ruthenocenyl moiety over the ferrocenyl one in interacting with proteins. We also report a 1.47 Å resolution crystal structure of Rc‐7‐ACA in complex with the CTX‐M‐14 E166A mutant, an enzyme sharing a similar active site configuration with penicillin‐binding proteins, the molecular target of β‐lactam antibiotics. These results strengthen the case for the antibacterial utility of the Rc and Fc groups. Abstract : Stronger than iron : Ruthenocenyl‐7‐aminocephalosporanic acid bound covalently in the active site of CTX‐M‐14 E166 A β‐lactamase and showed better antibacterial activity than the ferrocenyl counterpart. The 3‐acetyloxymethyl group was also found to enhance antibacterial activity. These data, provide valuable information for the future development of novel metallocenyl β‐lactam antibiotics.